Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 10 open reading frame 53 (C10orf53) is a protein encoded by the C10orf53 gene in humans[1][6]. The gene is located on chromosome 10q11.23, spans 30,611 nucleotides, and can generate at least two protein isoforms, the most common being 93 amino acids in length[1]. C10orf53 belongs to an uncharacterized protein family (UPF0728) and is predicted to evolve at a rate intermediate between rapidly and slowly evolving genes[1]. Its expression is tissue-specific, being highly enriched in the testes with minimal levels in organs like the cerebellum, liver, placenta, and trachea[1][5]. Within cells, C10orf53 is majorly cytoplasmic, with some presence in the nucleus and mitochondria. There are known post-translational modifications, including phosphorylation, SUMOylation, and acetylation sites[1]. Currently, the molecular function and biological processes involving C10orf53 are not well characterized. Some studies have identified protein-protein interactions with molecules such as the polymeric immunoglobulin receptor (PIGR), DSCC1, UXT, ZG16B, SPECC1L, MNAT1, and SPTB, hinting at roles in cellular transport, cytoskeletal organization, and possibly transcription regulation[1]. Clinical studies suggest C10orf53 expression strongly correlates with normal spermatogenesis and drops in conditions such as teratozoospermia[1]. There is also evidence implicating C10orf53 as detectable in exosomes from African American prostate cancer patients, though its role is not defined[1]. No drugs are known to target C10orf53, and it is not an established therapeutic target, receptor, enzyme, transporter, or transcription factor[1][6]. Note: - There is a similarly named gene, C11orf53, which has established therapeutic relevance and is known as POU2AF2, a transcription coactivator; C10orf53 is unrelated to this molecule[2]. - No established disease causality, mechanisms of action for targeting, or known interacting drugs for C10orf53 exist in the current literature[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 10 open reading frame 53 (C10orf53).